Clarent Corporation
CLRN
$0.00
$0.000.00%
| Weiss Ratings | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 85.62 | |||
| Price History | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -99.00% | |||
| 2-Year Total Return | -99.00% | |||
| 3-Year Total Return | -99.67% | |||
| 5-Year Total Return | -99.95% | |||
| 52-Week High % Change | -99.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 03, 2023 | |||
| 52-Week High Price (Date) | May 01, 2023 | |||
| Valuation | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 40.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -10.87 | |||
| Earnings Per Share Growth | 525.61% | |||
| Price/Earnings To Growth | 0.00 | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 40.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650-306-7511 | |||
| Address | 700 Chesapeake Drive Redwood City, CA 94063 | |||
| Website | www.clarent.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -250.63% | |||
| Profit Margin | -464.64% | |||
| Management Effectiveness | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -42.09% | |||
| Return on Equity | -- | |||
| Income Statement | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 94.59M | |||
| Total Revenue (TTM) | 94.59M | |||
| Revenue Per Share | $2.32 | |||
| Gross Profit (TTM) | -18.95M | |||
| EBITDA (TTM) | -172.22M | |||
| EBIT (TTM) | -237.08M | |||
| Net Income (TTM) | -439.51M | |||
| Net Income Avl. to Common (TTM) | -439.51M | |||
| Total Revenue Growth (Q YOY) | -31.16% | |||
| Earnings Growth (Q YOY) | -391.93% | |||
| EPS Diluted (TTM) | -10.87 | |||
| EPS Diluted Growth (Q YOY) | -339.73% | |||
| Balance Sheet | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 86.28M | |||
| Cash Per Share (Q) | $2.11 | |||
| Total Current Assets (Q) | 119.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 39.93M | |||
| Current Ratio (Q) | 1.607 | |||
| Book Value Per Share (Q) | $0.97 | |||
| Total Assets (Q) | 148.72M | |||
| Total Current Liabilities (Q) | 74.64M | |||
| Total Debt (Q) | 9.96M | |||
| Total Liabilities (Q) | 108.79M | |||
| Total Common Equity (Q) | 39.93M | |||
| Cash Flow | CLRN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 12.57M | |||
| Cash from Financing (TTM) | 14.70M | |||
| Net Change in Cash (TTM) | -130.66M | |||
| Levered Free Cash Flow (TTM) | -73.89M | |||
| Cash from Operations (TTM) | -157.69M | |||
